Skin diseases related to hepatitis B vaccine
Noble, J.P.; de Gennes, C.; Bousquet, O.
Gastroenterologie Clinique et Biologique 21(1): 87
1997
ISSN/ISBN: 0399-8320 PMID: 9091400 Document Number: 473199
Document emailed within 1 workday
Related Documents
Wang, H. 2014: The developing process of the event following hepatitis B Vaccine immunization and the related thinking and suggestion Zhonghua Yu Fang Yi Xue Za Zhi 48(6): 441-442Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Zoltan, C.; Jozsef, Z.; Sandor, K.; Laszlo, L.; Erzebet, V. 1975: Experience with the treatment of allergic skin diseases with mixed bacterial vaccine Orvosi Hetilap 116(17): 983-987
Margolis, H.S.; Presson, A.C. 1993: Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early JAMA 270(24): 2971-2972
Niebauer, G. 1980: Vacation-related skin diseases Zeitschrift für Hautkrankheiten 55(20): 1378-1387
Luksamijarulkul, P.; Chantavoraluk, S. 2013: Factors associated with hepatitis C infection among patients with skin diseases Journal of the Medical Association of Thailand 96(Suppl 5): S8-13
Maki, K. 1979: Viral hepatitis and HB antigen. Viral hepatitis and occupation-related diseases Nursing Technique 25(3): 96-111
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Hosokawa, H.; Horio, S.; Takiuchi, Y.; Maruyama, N.; Asada, Y. 1984: Naturally occurring T lymphocytotoxic antibody in viral and related skin diseases Acta Dermato-Venereologica 64(4): 275-280
Ma, Q.-s.; Zou, Y.-h.; Zhang, S.-x.; Liang, S.; Xiao, H.-w.; Xie, X.; Mei, S.-j.; Jia, W.-d.; Zhang, Y.-f.; Cui, F.-q.; Wang, F.-z.; Liang, X.-f. 2011: Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases Zhonghua Liu Xing Bing Xue Za Zhi 32(8): 764-767
Bravo, L.; Carlos, J.; Gatchalian, S.; Borja-Tabora, C.; Bibera, G.; Willems, P.; Safary, A.; Bock, H.L. 1998: The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 772-778
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
McIntyre, A.; Nimmo, G.R.; Wood, G.M.; Tinniswood, R.D.; Kerlin, P. 1992: Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Australian and New Zealand Journal of Medicine 22(1): 19-22
Inskip, H.M.; Hall, A.J.; Temple, I.K.; Loik, F.; Herbage, E.; Chotard, J.; Whittle, H. 1991: Response to hepatitis B vaccine in relation to the hepatitis B status of family members International Journal of Epidemiology 20(3): 770-773
Curciarello, J.O.; Corallini, O.; Adrover, R.E.; Chiera, A.O.; Giammona, A.M.; Barbero, R.; Apraiz, M.; Belloni, P.O.; Neumann, M.; Jmelnitzky, A.C. 1994: Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients Acta Gastroenterologica Latinoamericana 25(5): 291-296
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Woodruff, B.A.; Stevenson, J.; Yusuf, H.; Kwong, S.L.; Todoroff, K.P.; Hadler, J.L.; Hoyt, M.A.; Mahoney, F.J. 1996: Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group Pediatrics 97(6 Part 1): 798-803
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695